Patents by Inventor J. Blair West

J. Blair West has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALKALINE PHOSPHATASE FORMULATIONS
    Publication number: 20210220448
    Abstract: The present invention provides, in part, formulations comprising an alkaline phosphatase (AP)-based agent. Particularly, modified-release powder formulations comprising an AP-based agent are provided which release a substantial amount of the AP-based agent in the intestines. Therapeutic uses of the formulations are also provided.
    Type: Application
    Filed: March 29, 2021
    Publication date: July 22, 2021
    Inventors: Vincent WACHER, J. Blair WEST, Michael KALEKO, Christian FURLAN FREGUIA
  • Alkaline phosphatase formulations
    Patent number: 10987410
    Abstract: The present invention provides, in part, formulations comprising an alkaline phosphatase (AP)-based agent. Particularly, modified-release powder formulations comprising an AP-based agent are provided which release a substantial amount of the AP-based agent in the intestines. Therapeutic uses of the formulations are also provided.
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: April 27, 2021
    Assignee: Synthetic Biologics, Inc.
    Inventors: Vincent Wacher, J. Blair West, Michael Kaleko, Christian Furlan Freguia
  • BETA-LACTAMASE FORMULATIONS
    Publication number: 20200108130
    Abstract: The present invention provides, in part, formulations comprising a beta-lactamase. Particularly, modified-release powder formulations comprising a beta-lactamase are provided which release a substantial amount of the beta-lactamase in the intestines. Therapeutic uses of the beta-lactamase formulations are also provided.
    Type: Application
    Filed: March 20, 2018
    Publication date: April 9, 2020
    Inventors: Andrew BRISTOL, Klaus GOTTLIEB, J. Blair WEST
  • ALKALINE PHOSPHATASE FORMULATIONS
    Publication number: 20180326018
    Abstract: The present invention provides, in part, formulations comprising an alkaline phosphatase (AP)-based agent. Particularly, modified-release powder formulations comprising an AP-based agent are provided which release a substantial amount of the AP-based agent in the intestines. Therapeutic uses of the formulations are also provided.
    Type: Application
    Filed: July 17, 2018
    Publication date: November 15, 2018
    Inventors: Vincent WACHER, J. Blair WEST, Michael KALEKO, Christian FURLAN FREGUIA
  • Enantiomeric enrichment of bicyclic alcohols
    Patent number: 5726344
    Abstract: There is disclosed a two-stage enzymatically catalyzed reaction for the selective preparation of the (R)-endo-isomer of norbornenol from a mixture containing all four stereo- and regioisomers of norbornenol, as well as the synthesis of the intermediate product comprising the enantiomerically enriched mono-ester of (R)-endo-norbornenol and a diacid, and of the enantiomerically enriched saturated alcohol (R)-endo-norborneol. There is also disclosed a method for the production of (R)-endo-norborne-2-ol, by chemical reduction of either the enantiomerically enriched monoester and subsequent hydrolysis, or by hydrolysis of the enantiomerically enriched monoester and then chemical reduction.
    Type: Grant
    Filed: August 15, 1995
    Date of Patent: March 10, 1998
    Assignee: Bend Research, Inc.
    Inventors: J. Blair West, Keith DeVries